Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP).
Pediatric Blood and Cancer.
Times cited: 36
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.
Times cited: 137